BRCA2 and cancer: We have found that the ovarian cancer risk modifier SNP rs34259 may have a positive impact on UNG enzyme performance and is associated with lower oxidative levels in BRCA2 carriers, which may explain the cancer‐protective effect attributed to this SNP in this group.